PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RBS settlement in principle with US DOJ on RMBS

10 May 2018 07:00

RNS Number : 6230N
Royal Bank of Scotland Group PLC
10 May 2018
 

The Royal Bank of Scotland Group plc

 

RBS agrees in principle settlement with the US Department of Justice regarding US RMBS investigation

 

10 May 2018

 

The Royal Bank of Scotland Group plc (together with its subsidiaries, "RBS") today announces that it has reached a civil settlement in principle with the US Department of Justice ("DoJ") to resolve its investigation into RBS's issuance and underwriting of US residential mortgage-backed securities ("RMBS") between 2005 and 2007.

 

Under the terms of the proposed settlement, RBS has, in principle, agreed to pay a civil monetary cash penalty of US $4.9 billion (c. £3.6bn at the current exchange rate). Of this amount, US$3.46 billion will be covered by existing provisions with an incremental charge of US$ 1.44 billion in Q2 2018. The pro forma impact on RBS's 31 March 2018 Common Equity Tier 1 ratio ("CET1") is a reduction of approximately 50 basis points and a reduction of 9p on 31 March 2018 fully diluted TNAV per share. Adjusting for the combined impact of both the RMBS settlement and the pension deficit contribution of £2 billion announced on 17 April, the Q1 2018 pro forma CET1 is 15.1% and fully diluted TNAV is 274p.

 

Commenting on the developments, Ross McEwan (CEO), said,

 

"Today's announcement is a milestone moment for the bank. Reaching this settlement in principle with the US Department of Justice will, when finalised, allow us to deal with this significant remaining legacy issue and is the price we have to pay for the global ambitions pursued by this bank before the crisis. Removing the uncertainty over the scale of this settlement means that the investment case for this bank is much clearer." 

 

The proposed settlement is subject to the DOJ and RBS entering into a legally-binding agreement, and there can be no assurance that the parties will agree on the final terms of any proposed settlement.

 

The incremental charges will be booked in NatWest Markets plc ("NWM") on a consolidated basis. RBS retains its guidance on a NWM consolidated end state (post ring-fencing transfers) CET1 target of 14%, as per the outlook statement on p17 of RBS's 2017 Annual Report and Accounts ("FY2017 AR&A").

 

Separately, as at 31 March 2018, RBS held provisions of US$0.8 billion for other legacy RMBS matters. Please see RBS's FY2017 AR&A for further information.

 

 

Investor call

 

Ross McEwan (CEO) will host a conference call with Ewen Stevenson (CFO) for investors and analysts at 8:00am (UK) on Thursday 10 May. A replay of the call will be made available shortly afterwards. Only items relating to the above announcement will be discussed on the call; there will be no discussion relating to other matters or the Q2 2018 results.

 

Dial-in details:

UK: 0800 279 6637

International: + 44 (0) 203 0095755

US: +1 646 517 5063

Conference ID: 8162406

 

For further information, please contact:

 

Investor Relations

Matt Waymark

Head of Investor Relations

+44 (0) 207 672 1758

 

RBS Media Relations

+44 (0) 131 523 4205

 

MAR - Inside Information

 

This announcement Includes Inside information which is a disclosure required by the European Union Market Abuse Regulation EU 596/2014 of 16 April 2014. "Inside Information" is used as defined in that Regulation.

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK annual report and accounts and interim reports and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

Legal Entity Identifiers

The Royal Bank of Scotland Group plc

2138005O9XJIJN4JPN90

NatWest Markets plc

RR3QWICWWIPCS8A4S074

NatWest Markets Group Holdings Corporation

213800DHGZJXAXE8MM34

NatWest Markets Securities Inc

ZE2ZWJ5BTIQJ8M0C6K34

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEBLBFVEFXBBE
Date   Source Headline
15th Apr 20169:22 amRNSHolding(s) in Company
14th Apr 20165:32 pmRNSAllotment and Issue of New Ordinary Shares
11th Apr 20169:00 amRNSImpact of recent Liability Management Exercise
7th Apr 20162:32 pmRNSBlock listing Interim Review
7th Apr 201612:44 pmRNSPricing and Final Results
7th Apr 201612:43 pmRNSAnnouncement of Final Results
6th Apr 20165:20 pmRNSANNOUNCEMENT OF PRICING INFORMATION
1st Apr 20162:00 pmRNSNotice of AGM
31st Mar 20162:11 pmRNSTotal Voting Rights
31st Mar 20167:00 amRNSRBSG priced $1.5 billion Senior Notes
30th Mar 20161:04 pmRNSCASH TENDER OFFERS FOR EURO AND STERLING NOTES
30th Mar 20161:03 pmRNSCASH TENDER OFFERS ON CERTAIN US DOLLAR SECURITIES
29th Mar 20167:00 amRNSFILING OF ANNUAL REPORT ON FORM 20-F WITH THE SEC
22nd Mar 20167:50 amRNSRBS and HMT to retire the DAS
18th Mar 20162:31 pmRNSPublication of Final Terms
15th Mar 20168:45 amRNSMorgan Stanley European Financials Conference
8th Mar 20162:14 pmRNSDirector/PDMR Shareholding
7th Mar 20162:14 pmRNSPublication of Prospectus
29th Feb 20164:51 pmRNSTotal Voting Rights
29th Feb 20162:00 pmRNSDirector/PDMR Shareholding
26th Feb 20167:01 amRNSAnnual Report and Accounts 2015
26th Feb 20167:00 amRNSFinal Results
25th Feb 20165:36 pmRNSHome Member State Confirmations
25th Feb 20164:23 pmRNSDividend Declaration
4th Feb 20163:59 pmRNSRBS February 2016 Restatement
29th Jan 20162:55 pmRNSTotal Voting Rights
27th Jan 20167:00 amRNSTrading Statement
7th Jan 201611:02 amRNSHolding(s) in Company
6th Jan 201611:43 amRNSTotal Voting Rights
31st Dec 201510:50 amRNSTotal Voting Rights
17th Dec 20155:32 pmRNSAllotment and Issue of New Ordinary Shares
17th Dec 20158:59 amRNSAppointment of a Non-Executive Director
16th Dec 20157:27 amRNSUpdate on the disposal of Williams & Glyn - Amend
16th Dec 20157:00 amRNSUpdate on the disposal of Williams & Glyn
7th Dec 20157:20 amRNSDisposal of a portfolio of Irish Real Estate Loans
1st Dec 20157:07 amRNSStatement re 2015 stress test results
30th Nov 20153:15 pmRNSTotal Voting Rights
26th Nov 20155:19 pmRNSImpact of recent Liability Management Exercise
23rd Nov 20153:32 pmRNSPublication of Prospectus
19th Nov 20155:11 pmRNSDividend Declaration
12th Nov 201512:51 pmRNSRBS Investor Seminar: CIB
12th Nov 20159:54 amRNSDirector Declaration
10th Nov 20152:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20151:40 pmRNSVisa Europe Shareholding
30th Oct 20153:35 pmRNSTotal Voting Rights
30th Oct 201512:05 pmRNSDisposal
30th Oct 20157:05 amRNSSale of Remainder of Citizens Financial Group Inc.
30th Oct 20157:00 amRNSInterim Management Statement
15th Oct 20154:00 pmRNSHolding(s) in Company
14th Oct 20158:16 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.